Qiagen N.V. QIA.DE Stock
Qiagen N.V. Price Chart
Qiagen N.V. QIA.DE Financial and Trading Overview
Qiagen N.V. stock price | 36.89 EUR |
Previous Close | 40.8 EUR |
Open | 40.87 EUR |
Bid | 40.59 EUR x 48300 |
Ask | 40.61 EUR x 51100 |
Day's Range | 40.52 - 41.09 EUR |
52 Week Range | 32.74 - 47.72 EUR |
Volume | 477.53K EUR |
Avg. Volume | 607.55K EUR |
Market Cap | 9.26B EUR |
Beta (5Y Monthly) | 0.442 |
PE Ratio (TTM) | 30.466166 |
EPS (TTM) | 1.42 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | January 25, 2017 |
1y Target Est | 47.9 EUR |
QIA.DE Valuation Measures
Enterprise Value | 9.83B EUR |
Trailing P/E | 30.466166 |
Forward P/E | 23.287357 |
PEG Ratio (5 yr expected) | 1.85 |
Price/Sales (ttm) | 4.7344317 |
Price/Book (mrq) | 2.5030887 |
Enterprise Value/Revenue | 5.025 |
Enterprise Value/EBITDA | 18.382 |
Trading Information
Qiagen N.V. Stock Price History
Beta (5Y Monthly) | 0.442 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 47.72 EUR |
52 Week Low | 32.74 EUR |
50-Day Moving Average | 38.84 EUR |
200-Day Moving Average | 39.8 EUR |
QIA.DE Share Statistics
Avg. Volume (3 month) | 607.55K EUR |
Avg. Daily Volume (10-Days) | 552.14K EUR |
Shares Outstanding | 228.18M |
Float | 226.49M |
Short Ratio | N/A |
% Held by Insiders | 0.36% |
% Held by Institutions | 75.33% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 26:27 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | September 30, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 24.79% |
Operating Margin (ttm) | 22.52% |
Gross Margin | 65.98% |
EBITDA Margin | 27.33% |
Management Effectiveness
Return on Assets (ttm) | 4.41% |
Return on Equity (ttm) | 13.81% |
Income Statement
Revenue (ttm) | 1.96B EUR |
Revenue Per Share (ttm) | 8.58 EUR |
Quarterly Revenue Growth (yoy) | -4.79% |
Gross Profit (ttm) | N/A |
EBITDA | 534.58M EUR |
Net Income Avi to Common (ttm) | 484.93M EUR |
Diluted EPS (ttm) | 1.33 |
Quarterly Earnings Growth (yoy) | -5.60% |
Balance Sheet
Total Cash (mrq) | 1.02B EUR |
Total Cash Per Share (mrq) | 4.45 EUR |
Total Debt (mrq) | 1.53B EUR |
Total Debt/Equity (mrq) | 41.5 EUR |
Current Ratio (mrq) | 3.742 |
Book Value Per Share (mrq) | 16.188 |
Cash Flow Statement
Operating Cash Flow (ttm) | 468.26M EUR |
Levered Free Cash Flow (ttm) | 73.76M EUR |
Profile of Qiagen N.V.
Country | Germany |
State | N/A |
City | Venlo |
Address | Hulsterweg 82 |
ZIP | 5912 PL |
Phone | 31 77 355 6600 |
Website | https://www.qiagen.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 6000 |
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping, and gene regulation instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR solutions; and developed and configured OEM consumables. Further, the company provides predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.
Q&A For Qiagen N.V. Stock
What is a current QIA.DE stock price?
Qiagen N.V. QIA.DE stock price today per share is 36.89 EUR.
How to purchase Qiagen N.V. stock?
You can buy QIA.DE shares on the XETRA exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Qiagen N.V.?
The stock symbol or ticker of Qiagen N.V. is QIA.DE.
Which industry does the Qiagen N.V. company belong to?
The Qiagen N.V. industry is Diagnostics & Research.
How many shares does Qiagen N.V. have in circulation?
The max supply of Qiagen N.V. shares is 228.74M.
What is Qiagen N.V. Price to Earnings Ratio (PE Ratio)?
Qiagen N.V. PE Ratio is 26.84155000 now.
What was Qiagen N.V. earnings per share over the trailing 12 months (TTM)?
Qiagen N.V. EPS is 1.42 EUR over the trailing 12 months.
Which sector does the Qiagen N.V. company belong to?
The Qiagen N.V. sector is Healthcare.
Qiagen N.V. QIA.DE included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
TECDAX TR TECDAX | 3326.26 EUR 3636.05 USD |
-0.84
|
— — | 3318.64 EUR 3627.72 USD | 3398.02 EUR 3714.49 USD | — - | — — |
DAX PERFORMANCE-INDEX GDAXI | 17930.32 EUR 19600.26 USD |
-0.13
|
— — | 17860.73 EUR 19524.19 USD | 18162.56 EUR 19854.13 USD | — - | — — |
- {{ link.label }} {{link}}